CLOV - Clover Health Investments, Corp.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$3.33
DETAILS
HIGH:
$6.00
LOW:
$1.80
MEDIAN:
$2.75
CONSENSUS:
$3.33
DOWNSIDE:
6.20%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 1,924.3 | 1,371.1 | 1,260.5 | 1,096.6 | 1,472.0 | 672.9 | 462.3 | 281.0 |
| Cost of Revenue | 1,568.4 | 1,006.3 | 1,004.6 | 993.1 | 1,551.2 | 590.1 | 449.7 | 0 |
| Gross Profit | 355.9 | 364.8 | 256.0 | 103.5 | (79.2) | 82.8 | 12.6 | 281.0 |
| Operating Expenses | ||||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 176.3 | 408.9 | 440.2 | 482.4 | 445.7 | 192.1 | 187.3 | 187.3 |
| Other Expenses | 265.1 | 1.6 | 21.0 | (92.3) | 112.1 | (16.6) | 8.4 | 280.4 |
| Operating Expenses | 441.4 | 410.6 | 461.3 | 390.1 | 557.8 | 175.5 | 195.8 | 476.0 |
| Operating Income | ||||||||
| Operating Income | (85.5) | (45.7) | (205.3) | (286.7) | (637.0) | (92.7) | (183.2) | (185.8) |
| Interest Expense | 0 | 0 | 0.0 | 1.4 | 16.9 | 57.1 | 39.1 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.0 |
| Profitability | ||||||||
| EBITDA | (83.9) | (44.9) | (207.6) | (252.0) | (569.6) | (78.7) | (324.1) | (16.1) |
| EBIT | (85.5) | (46.3) | (210.1) | (253.2) | (570.8) | (79.3) | (324.7) | (372.5) |
| Income Before Tax | (85.5) | (46.3) | (210.1) | (254.6) | (587.8) | (136.4) | (363.7) | (201.9) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (85.5) | (43.0) | (213.4) | (339.6) | (587.8) | (136.4) | (363.7) | (201.9) |
| Per Share Data | ||||||||
| EPS (Basic) | -0.17 | -0.09 | -0.45 | -0.71 | -1.25 | -0.23 | -0.90 | -4.81 |
| EPS (Diluted) | -0.17 | -0.09 | -0.45 | -0.71 | -1.25 | -0.23 | -0.90 | -4.81 |
| Shares Outstanding | 517.2 | 490.0 | 482.2 | 476.2 | 470.9 | 404.4 | 404.4 | 42.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 78.3 | 194.5 | 116.4 | 103.8 | 300.0 | 92.3 | 0 | 75.4 |
| Short-Term Investments | 17.0 | 27.0 | 119.8 | 231.0 | 315.3 | 4.4 | 0 | 0 |
| Net Receivables | 158.7 | 92.8 | 86.2 | 167.5 | 109.4 | 84.9 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 53.8 | 15.6 | 91.1 | 104.5 | 13.2 | 0.3 | 0 | 0 |
| Total Current Assets | 307.9 | 343.1 | 428.0 | 625.0 | 752.5 | 189.8 | 0 | 75.4 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 6.4 | 5.3 | 5.1 | 9.8 | 7.7 | 10.0 | 0 | 3.2 |
| Goodwill | 0 | 0 | 0 | 11.7 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.0 | 3.0 | 3.0 | 8.3 | 4.2 | 4.2 | 0 | 3.0 |
| Long-Term Investments | 187.1 | 201.7 | 121.0 | 138.1 | 175.9 | 54.4 | 0 | 0 |
| Other Non-Current Assets | 36.7 | 27.6 | 13.6 | 15.7 | 10.4 | 8.9 | 0.1 | 129.0 |
| Total Non-Current Assets | 233.2 | 237.6 | 142.7 | 183.6 | 198.3 | 77.5 | 0.1 | 135.2 |
| Total Assets | 541.0 | 580.7 | 570.7 | 808.6 | 950.8 | 267.3 | 0.1 | 210.6 |
| Current Liabilities | ||||||||
| Account Payables | 153.2 | 34.6 | 37.2 | 32.4 | 28.1 | 30.7 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 20.8 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 3.1 | 0 | 138.6 | 102.4 | 0 | 0 |
| Other Current Liabilities | 55.6 | 22.6 | 61.1 | 81.6 | 9.0 | (102.4) | 0 | 0 |
| Total Current Liabilities | 208.8 | 213.5 | 261.1 | 431.5 | 372.6 | 164.2 | 0.1 | 6.0 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 19.9 | 106.4 | 0 | 49.3 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 23.5 | 26.1 | 20.2 | 16.2 | 14.1 | 603.5 | 0 | 210.1 |
| Total Non-Current Liabilities | 23.5 | 26.1 | 23.2 | 20.2 | 38.9 | 716.2 | 0 | 259.4 |
| Total Liabilities | 232.3 | 239.6 | 284.3 | 451.7 | 411.5 | 880.4 | 0.1 | 265.4 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (2,288.4) | (2,202.8) | (2,159.8) | (1,946.4) | (1,616.7) | (1,029.0) | (0.0) | (527.9) |
| Accumulated Other Comprehensive Income | 0.5 | (1.6) | (2.4) | (9.4) | (1.9) | 0.0 | 0 | 0 |
| Total Stockholders' Equity | 308.7 | 341.1 | 286.4 | 356.9 | 535.4 | (617.1) | (0.0) | (54.8) |
| Total Liabilities & Equity | 541.0 | 580.7 | 570.7 | 808.6 | 950.8 | 267.3 | 0.1 | 210.6 |
| Debt Metrics | ||||||||
| Total Debt | 0 | 0 | 4.7 | 5.9 | 27.8 | 138.4 | 0 | 49.3 |
| Net Debt | (78.3) | (194.5) | (111.7) | (97.9) | (272.1) | 46.0 | 0 | (26.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (85.5) | (43.0) | (213.4) | (339.6) | (587.8) | (136.4) | (363.7) | (201.9) |
| Depreciation & Amortization | 1.7 | 1.3 | 2.5 | 1.2 | 1.2 | 0 | 0.6 | 0.5 |
| Stock-Based Compensation | 103.7 | 114.3 | 140.9 | 164.3 | 163.7 | 0 | 3.3 | 3.7 |
| Change in Working Capital | (84.2) | 12.9 | (55.4) | (2.4) | 192.7 | (24.5) | 32.3 | 35.0 |
| Other Non-Cash Items | (2.5) | (50.7) | 9.5 | (27.5) | 13.9 | 42.4 | 167.7 | 9.5 |
| Operating Cash Flow | (66.9) | 34.8 | (115.9) | (203.9) | (282.3) | (118.5) | (159.9) | (153.3) |
| Investing Activities | ||||||||
| Capital Expenditure | (2.0) | (1.6) | (0.6) | (4.5) | (0.7) | (0.7) | (0.0) | (1.5) |
| Acquisitions | 0 | 0 | 0 | (16.2) | 434.7 | 3.9 | (1.2) | 0 |
| Purchases of Investments | (205.1) | (201.2) | (175.6) | (369.6) | (876.3) | (174.3) | (505.5) | 0 |
| Sales/Maturities of Investments | 211.2 | 203.4 | 316.2 | 485.4 | 441.5 | 312.4 | 324.8 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (434.7) | 0 | 0 | 99.0 |
| Investing Cash Flow | 4.1 | 0.6 | 140.0 | 95.1 | (435.4) | 141.3 | (181.9) | 97.5 |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (30.9) | 1.1 | 333.7 | 29.8 |
| Stock Repurchased | (55.2) | (18.3) | (6.2) | (6.4) | (0.1) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (28.8) | 0 | 666.5 | (1.0) | (0.4) | 44.8 |
| Financing Cash Flow | (53.4) | (17.4) | (33.9) | (5.0) | 925.4 | 1.9 | 334.0 | 74.6 |
| Cash Position | ||||||||
| Net Change in Cash | (116.2) | 18.0 | (9.7) | (113.8) | 207.6 | 92.3 | (7.8) | 18.8 |
| Cash at Beginning | 194.5 | 176.5 | 186.2 | 300.0 | 92.3 | 0 | 75.4 | 56.6 |
| Cash at End | 78.3 | 194.5 | 176.5 | 186.2 | 300.0 | 92.3 | 67.6 | 75.4 |
| Free Cash Flow | (69.0) | 33.3 | (116.5) | (208.4) | (283.0) | (119.2) | (159.9) | (154.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,924.3 | 1,371.1 | 1,260.5 | 1,096.6 | 1,472.0 | 672.9 | 462.3 | 281.0 |
| Gross Profit | 355.9 | 364.8 | 256.0 | 103.5 | (79.2) | 82.8 | 12.6 | 281.0 |
| Operating Income | (85.5) | (45.7) | (205.3) | (286.7) | (637.0) | (92.7) | (183.2) | (185.8) |
| Net Income | (85.5) | (43.0) | (213.4) | (339.6) | (587.8) | (136.4) | (363.7) | (201.9) |
| EPS (Diluted) | -0.17 | -0.09 | -0.45 | -0.71 | -1.25 | -0.23 | -0.90 | -4.81 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 78.3 | 194.5 | 116.4 | 103.8 | 300.0 | 92.3 | 0 | 75.4 |
| Total Assets | 541.0 | 580.7 | 570.7 | 808.6 | 950.8 | 267.3 | 0.1 | 210.6 |
| Total Debt | 0 | 0 | 4.7 | 5.9 | 27.8 | 138.4 | 0 | 49.3 |
| Stockholders' Equity | 308.7 | 341.1 | 286.4 | 356.9 | 535.4 | (617.1) | (0.0) | (54.8) |
| Cash Flow | ||||||||
| Operating Cash Flow | (66.9) | 34.8 | (115.9) | (203.9) | (282.3) | (118.5) | (159.9) | (153.3) |
| Capital Expenditure | (2.0) | (1.6) | (0.6) | (4.5) | (0.7) | (0.7) | (0.0) | (1.5) |
| Free Cash Flow | (69.0) | 33.3 | (116.5) | (208.4) | (283.0) | (119.2) | (159.9) | (154.8) |